Search Share Prices
GSK News - AstraZeneca says Fasenra misses main goal in COPD trial
AstraZeneca (LON:AZN) said on Wednesday its asthma treatment Fasenra did not meet the primary endpoint in a late-stage trial for patients with chronic obstructive pulmonary disease (COPD).
GSK, Lilly join $350bn wave of U.S. drug investments amid tariff threat
Investing.com-- GSK (LON:GSK) and Eli Lilly (NYSE:LLY) announced fresh U.S. manufacturing investments on Tuesday, joining a wave of global drugmakers ramping up domestic capacity as the Trump ...
GSK and Eli Lilly Announce Billions in U.S. Manufacturing Investments Amid Tariff Concerns
GlaxoSmithKline (GSK) and Eli Lilly are making major U.S. manufacturing commitments as global pharmaceutical companies expand domestic operations in response to possible tariffs on imported medicines.
Drugmakers have pledged $350 bln in US investments after tariff threat - WSJ
According to the WSJ’s tally, more than a dozen drugmakers have pledged over $350 billion in U.S. investments this decade, partly to offset potential tariff costs.
GSK’s new antibiotic for urinary tract infections gets U.K. approval
Investing.com -- GSK plc (LON:GSK) has received U.K. regulatory approval for its oral antibiotic treatment for uncomplicated urinary tract infections (UTIs), marking the first new type of oral ...